HeartRhythm

MARCH 26, 2024

On January 7, 2024, our cardiac electrophysiology community lost Bruce L. Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs). Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm Society (HRS).

Heart Rhythm 45

Heart Rhythm Electrophysiology Innovation Technology 45

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. Antonius Hospital, Netherlands , professor of electrophysiology, Amsterdam UMC , and lead investigator of the FARADISE registry. “We director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.

Atrial Fibrillation 105

Atrial Fibrillation Heart Rhythm Ablation Quality of Life 105

DAIC

JANUARY 19, 2024

“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. The credit goes to my mentees and colleagues over the years.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

DAIC

MARCH 1, 2024

“The entire digital electrocardiogram signal performed significantly better than a few of its components,” said Chugh, who is also the Pauline and Harold Price Chair in Cardiac Electrophysiology Research and associate director in the Smidt Heart Institute. “We

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Electrophysiology Defibrillator 111

DAIC

JANUARY 18, 2024

We have long known that pulsed field ablation could open up an entirely new frontier in how we treat people battling the most complex cardiac arrhythmias. But like any innovation, early solutions have not been able to fully capitalize on those potential benefits," said Professor Prash Sanders, M.B.B.S.,

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

DAIC

OCTOBER 30, 2024

Director of Cardiac Arrhythmia Services for the Mount Sinai Health System in New York City. The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients. The potential of Affera is limitless.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

DAIC

JANUARY 24, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease. Patients come to us from all over the U.S. and overseas for our expertise.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

APRIL 9, 2024

It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. Antiarrhythmic drugs are advised for some patients to prevent arrhythmia recurrences early after the procedure.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

Dr. S. Venkatesan MD

JUNE 16, 2024

Any deviation or trespassing results in arrhythmia. The term, VT mapping has been in vogue in clinical electrophysiology for more than half a century, right from Dr.Josephson and Wellens’ days. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ?

Ablation 52

Ablation Physiology Technology Electrophysiology 52

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias. Infusion and uptake of calcium chloride during pulsed field ablation leads to greater irreversible electroporation and larger myocardial ablation lesions.

Ablation 45

Ablation Innovation Arrhythmia Research 45

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY. David's Medical Center.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

DECEMBER 26, 2023

Through relentless innovation, unwavering dedication, and commitment to pushing the boundaries of what is possible in bioelectric energy, we are reshaping the future of the treatment for atrial fibrillation with our cardiac catheter in electrophysiology and with our cardiac clamp in cardiothoracic surgery.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59

DAIC

APRIL 6, 2024

Chugh, the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai, investigates the causes of and potential treatments for abnormal heart rhythms, including sudden cardiac arrest. EDT, and she will co-chair electrophysiology research presentations.

Research 105

Research Cardiac Arrest Electrophysiology Chest Pain 105

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59